Previous Article | Next Article ![]()
Journal of Virology, April 2001, p. 3605-3612, Vol. 75, No. 8
HIV and Retrovirology Branch, Division of
AIDS, STD, and TB Laboratory Research, National Center for
Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia 30333
Received 14 November 2000/Accepted 12 January 2001
Previous findings of low levels of reverse transcriptase (RT)
activity in chick cell-derived measles and mumps vaccines showed this
activity to be associated with virus particles containing RNA of both
subgroup E endogenous avian leukosis viruses (ALV-E) and endogenous
avian viruses (EAV). These particles originate from chicken embryonic
fibroblast (CEF) substrates used for propagating vaccine strains. To
better characterize vaccine-associated ALV-E, we examined the
endogenous ALV proviruses (ev loci) present in a White
Leghorn CEF substrate pool by restriction fragment length polymorphism.
Five ev loci were detected, ev-1, ev-3, ev-6,
ev-18, andev-19. Both ev-18 and
ev-19 can express infectious ALV-E, while ev-1,
ev-3, and ev-6 are defective. We analyzed the
full-length sequence of ev-1 and identified an adenosine
insertion within the pol RT-
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3605-3612.2001
Characterization of Endogenous Avian Leukosis
Viruses in Chicken Embryonic Fibroblast Substrates Used in
Production of Measles and Mumps Vaccines
region at position 5026, which results in a truncated RT-
and integrase. We defined the
1,692-bp deletion in the gag-pol region of
ev-3, and we found that in ev-6, sequences from
the 5' long terminal repeat to the 5' pol region were
absent. Based on the sequences of the ev loci, RT-PCR
assays were developed to examine expression of ALV-E particles (EV) in
CEF supernatants. Both ev-1- and ev-3-like RNA
sequences were identified, as well as two other RNA sequences with
intact pol regions, presumably of ev-18 and
ev-19 origin. Inoculation of susceptible quail fibroblasts with CEF culture supernatants from both 5-azacytidine-induced and
noninduced CEF led to ALV infection, confirming the presence of
infectious ALV-E. Our data demonstrate that both defective and
nondefective ev loci can be present in CEF vaccine
substrates and suggest that both ev classes may contribute
to the ALV present in vaccines.
*
Corresponding author. Mailing address: HIV and
Retrovirology Branch, CDC, 1600 Clifton Rd., Mail Stop G-19, Atlanta,
GA 30333. Phone: (404) 639-0218. Fax: (404) 639-1174. E-mail:
WMH2{at}cdc.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»